» Articles » PMID: 38704512

Mesenchymal Stem Cells Pretreated with Interferon-gamma Attenuate Renal Fibrosis by Enhancing Regulatory T Cell Induction

Overview
Journal Sci Rep
Specialty Science
Date 2024 May 4
PMID 38704512
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) exert their anti-inflammatory and anti-fibrotic effects by secreting various humoral factors. Interferon-gamma (IFN-γ) can enhance these effects of MSCs, and enhancement of regulatory T (Treg) cell induction is thought to be an underlying mechanism. However, the extent to which Treg cell induction by MSCs pretreated with IFN-γ (IFN-γ MSCs) ameliorates renal fibrosis remains unknown. In this study, we investigated the effects of Treg cell induction by IFN-γ MSCs on renal inflammation and fibrosis using an siRNA knockdown system. Administration of IFN-γ MSCs induced Treg cells and inhibited infiltration of inflammatory cells in ischemia reperfusion injury (IRI) rats more drastically than control MSCs without IFN-γ pretreatment. In addition, administration of IFN-γ MSCs more significantly attenuated renal fibrosis compared with control MSCs. Indoleamine 2,3-dioxygenase (IDO) expression levels in conditioned medium from MSCs were enhanced by IFN-γ pretreatment. Moreover, IDO1 knockdown in IFN-γ MSCs reduced their anti-inflammatory and anti-fibrotic effects in IRI rats by reducing Treg cell induction. Our findings suggest that the increase of Treg cells induced by enhanced secretion of IDO by IFN-γ MSCs played a pivotal role in their anti-fibrotic effects. Administration of IFN-γ MSCs may potentially be a useful therapy to prevent renal fibrosis progression.

Citing Articles

Regulation of Colonic Inflammation and Macrophage Homeostasis of IFN-γ-Primed Canine AMSCs in Experimental Colitis in Mice.

Jo C, Lee S, Son Y, Lee W, Choe Y, Lee H Animals (Basel). 2024; 14(22).

PMID: 39595338 PMC: 11591378. DOI: 10.3390/ani14223283.


Kynurenine Pathway after Kidney Transplantation: Friend or Foe?.

Zakrocka I, Urbanska E, Zaluska W, Kronbichler A Int J Mol Sci. 2024; 25(18).

PMID: 39337426 PMC: 11432217. DOI: 10.3390/ijms25189940.


Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice.

Hamidi S, Etebar N, Rahimzadegan M, Zali A, Roodsari S, Niknazar S Mol Cell Biochem. 2024; 479(7):1643-1671.

PMID: 38977625 DOI: 10.1007/s11010-024-05051-8.

References
1.
Huang B, Cheng X, Wang H, Huang W, la Ga Hu Z, Wang D . Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016; 14:45. PMC: 4746907. DOI: 10.1186/s12967-016-0792-1. View

2.
Doreille A, Azzi F, Lariviere-Beaudoin S, Karakeussian-Rimbaud A, Trudel D, Hebert M . Acute Kidney Injury, Microvascular Rarefaction, and Estimated Glomerular Filtration Rate in Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2021; 16(3):415-426. PMC: 8011007. DOI: 10.2215/CJN.07270520. View

3.
Casiraghi F, Azzollini N, Cassis P, Imberti B, Morigi M, Cugini D . Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol. 2008; 181(6):3933-46. DOI: 10.4049/jimmunol.181.6.3933. View

4.
Shi Y, Hu G, Su J, Li W, Chen Q, Shou P . Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 2010; 20(5):510-8. DOI: 10.1038/cr.2010.44. View

5.
Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A . Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2005; 24(2):386-98. DOI: 10.1634/stemcells.2005-0008. View